Article Sidebar

Published
Nov 17, 2025
Download
PDF
Statistic
Read Counter: 4 Download: 6

Main Article Content

Abstract

Solanum pubescens Willd., belongs to the family Solanaceae, have pharmacological actions like hepatoprotective, gastroprotective, anti-inflammatory, antimicrobial, antihelmethic.
Objetive: To investigate antioxidant activity of methanolic leaf extract of Solanum pubescens Willd., on alloxan induced diabetic rats.
Methods: Alloxan is administered as an inducer for diabetes. Thirty Wistar albino rats were randomly divided into five groups. Either sex of Wister strains of albino rats were divided in to 5 groups were Group 1 served as normal control, Group 2 served as alloxan control, Group 3 were administered with standard drug (Glibenclamide), Group 4 and Group 5 were administered to different doses of methanolic extract of Solanum pubescens Willd., (i.e. 200 and 300 mg/kg/Kg body weight).The anti-diabetic activity was determined by glucometer in both normal and alloxan-induced diabetic rats. The methanolic extract of Solanum Pubescens showed significant reduction in blood glucose levels due to the presence of phytochemicals such as alkaloids in extracts.
Results: Altered levels of the FBGL and OGTT in alloxan induced rats were brought back to normal on treatment with methanolic extract of Solanum pubescens Willd., Thus the positive results suggest that solanum Pubescens extract should be further studied to determine the bioactive chemical compounds as well as to understand the possible mechanism of action and evaluate their toxicity looking towards pharmaceutical actions.
Conclusion: It was concluded from the result that the methanolic extract of Solanum pubescens Willd., showed significant antidiabetic activity in a dose dependent manner.

Keywords

Solanum pubescens Willd., Antidiabetic activity, Glibenclamide, FBGL and OGTT.

Article Details

References

  1. 1. Consultation, W. H. O. Definition, diagnosis and classification of diabetes mellitus and its complications. Vol. 1. Part, 1999.
  2. 2. Alberti, Kurt George Matthew Mayer, and PZ ft Zimmet. "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation." Diabetic medicine 15.7 (1998): 539-553.
  3. 3. Gress, Todd W., et al. "Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus." New England Journal of Medicine 342.13 (2000): 905-912.
  4. 4. Ahmed, Awad M. "History of diabetes mellitus." Saudi medical journal 23.4 (2002): 373-378.
  5. 5. Zimmet, Paul Z., Daniel J. McCarty, and Maximilian P. de Courten. "The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome." Journal of Diabetes and its Complications 11.2 (1997): 60-68.
  6. 6. American Diabetes Association. "Type 2 diabetes in children and adolescents."Pediatrics 105.3 (2000): 671-680.
  7. 7. Saltiel, Alan R., and C. Ronald Kahn. "Insulin signalling and the regulation of glucose and lipid metabolism." Nature 414.6865 (2001): 799-806.
  8. 8. Browning, Jeffrey D., and Jay D. Horton. "Molecular mediators of hepatic steatosis and liver injury." Journal of Clinical Investigation 114.2 (2004): 147-152.
  9. 9. Aronoff, Stephen L., et al. "Glucose metabolism and regulation: beyond insulin and glucagon." Diabetes Spectrum 17.3 (2004): 183-190.
  10. 10. Ross, E. J., and D. C. Linch. "Cushing's syndrome—killing disease: discriminatory value of signs and symptoms aiding early diagnosis." The Lancet320.8299 (1982): 646-649.
  11. 11. Levin, Marvin E., Vincenza C. Boisseau, and Louis V. Avioli. "Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes." New England Journal of Medicine 294.5 (1976): 241-245.
  12. 12. Sherwin, Robert, and Philip Felig. "Pathophysiology of diabetes mellitus." The Medical clinics of North America 62.4 (1978): 695-711.
  13. 13. Faber, O. K., and C. Binder. "C-peptide response to glucagon: a test for the residual β-cell function in diabetes mellitus." Diabetes 26.7 (1977): 605-610.
  14. 14. Ioannidis, Ioannis. "Pathophysiology of Type 1 diabetes." Diabetes in Clinical Practice: Questions and Answers from Case Studies 31 (2007): 23.
  15. 15. Scheen, A. J. "Pathophysiology of type 2 diabetes." Acta Clinica Belgica 58.6 (2003): 335-341.
  16. 16. Vambergue, A., et al. "[Pathophysiology of gestational diabetes]." Journal de gynecologie, obstetrique et biologie de la reproduction 31.6 Suppl (2002): 4S3-4S10.
  17. 17. Inzucchi, Silvio E. "Diagnosis of diabetes." New England Journal of Medicine367.6 (2012): 542-550.
  18. 18. Turner, R. C., et al. "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)." lancet 352.9131 (1998): 837-853.
  19. 19. Brownlee, M., and A. Cerami. "The biochemistry of the complications of diabetes mellitus." Annual review of biochemistry 50.1 (1981): 385-432.
  20. 20. Pari, L., and G. Saravanan. "Antidiabetic effect of Cogent db, a herbal drug in alloxan-induced diabetes mellitus." Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 131.1 (2002): 19-25.
  21. 21. Day, Caroline. "Traditional plant treatments for diabetes mellitus: pharmaceutical foods." British Journal of Nutrition 80.01 (1998): 5-6.
  22. 22. Smith, George Davey, et al. "Genetic epidemiology and public health: hope, hype, and future prospects." The Lancet 366.9495 (2005): 1484-1498.
  23. 23. Hemamalini, K., et al. "Gastroprotective Activity of Gymnosporia emerginata, Solanum pubescence and Anogessius accuminata Leaf Extract against Ethanol-induced Gastric mucosal injury in Rats." International Journal of Pharmaceutical and Biomedical Research 2.1 (2011): 38-42.
  24. 24. Rahman, Haseeb Ur, et al. "PHYTOCHEMICAL PROFILING OF SUCCESSIVE EXTRACTS OF FRUIT AND STEM BARK OF SOLANUM PUBESCENS."International Journal of Pharmacy and Pharmaceutical Sciences 6.9 (2014).
  25. 25. SUMALATHA, PEDDI, K. HEMAMALINI, and M. VIJUSHA. "ANTI OXIDANT PROPERTY METHANOLIC EXTRACT OF Solanum pubescens Willd., ON PARACETAMOL INDUCED OXIDATIVE STRESS IN ALBINO RATS."
  26. 26. HEMAMALINI, K., and A. SAMBASIVA RAO. "ANTI ULCEROGENIC MODELS OF SOPHORA INTERRUPTA SOLANUM PUBESCENS AND TABEBUIA ROSEA LEAVES ON INVIVO TEST MODEL IN RATS."International Journal of Pharmacy & Pharmaceutical Sciences 6.6 (2014).
  27. 27. Rahman, Haseeb Ur, et al. "PHYTOCHEMICAL PROFILING OF SUCCESSIVE EXTRACTS OF FRUIT AND STEM BARK OF SOLANUM PUBESCENS."International Journal of Pharmacy and Pharmaceutical Sciences 6.9 (2014).
  28. 28. Hemamalini, K., et al. "Gastroprotective Activity of Gymnosporia emerginata, Solanum pubescence and Anogessius accuminata Leaf Extract against Ethanol-induced Gastric mucosal injury in Rats." International Journal of Pharmaceutical and Biomedical Research 2.1 (2011): 38-42.
  29. 29. Pushpalatha, M., and T. Ananthi. "Protective Effect of SolanumpubescensLINN on CCl4Induced Hepatotoxicity in Albino Rats." Mintage Journal of Pharmaceutical and Medicinal Science 1.1 (2012): 11-13.
  30. 30. Hemamalini, K., and Anurag Bhargava. "Preclinical efficacy and safety of herbal formulation for management of wounds." International Journal of Pharmaceutical Science and Research 4.9 (2013): 3466-3470.
  31. 31. Bhargav, Anurag, Et Al. "Antidiarrheal Activity Of Methanolic Extract Of Leaves Of Solanum Pubescenswilld And Gymnosporia Emerginata." Asian Journal Of Pharmaceutical And Clinical Research 5.3 (2012): 226-227.
  32. 32. Sharath, Goud t. "In-Vitro Anthelmintic Activity Of Solanam Pubescens And Gymnosporia Emerginata Leave."
  33. 33. Bhaargavi, Vuyyuri, G. S. L. Jyotsna, and Reshma Tripurana. "A REVIEW ON HEPATOPROTECTIVE ACTIVITY." International Journal of Pharmaceutical Sciences & Research 5.3 (2014).
  34. 34. ON, ANTIAMNESIC ACTIVITY OF GUGGUL EXTRACT, and ALBINO WISTAR RATS. "International Journal of Pharmacy."
  35. 35. Schmidt, Adam, et al. "Polymethylated myricetin in trichomes of the wild tomato species Solanum habrochaites and characterization of trichome-specific 3′/5′-and 7/4′-myricetin O-methyltransferases." Plant physiology 155.4 (2011): 1999-2009.
  36. 36. LIU, Yu-Bo, et al. "Chemical Constituents of< i> Toona ciliata var.< i> pubescens." Chinese Journal of Natural Medicines 9.2 (2011): 115-119.
  37. 37. Alarcon-Aguilara, F. J., et al. "Study of the anti-hyperglycemic effect of plants used as antidiabetics." Journal of Ethnopharmacology 61.2 (1998): 101-110.
  38. 38. Andrade-Cetto, Adolfo, and Michael Heinrich. "Mexican plants with hypoglycaemic effect used in the treatment of diabetes." Journal of ethnopharmacology 99.3 (2005): 325-348.
  39. 39. Patel, D. K., et al. "Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity." Asian Pacific journal of tropical biomedicine 2.5 (2012): 411-420.
  40. 40. Fatima, Amreen, Parul Agrawal, and Prem Prakash Singh. "Herbal option for diabetes: an overview." Asian Pacific Journal of Tropical Disease 2 (2012): S536-S544.
  41. 41. Pushpalatha, M., and T. Ananthi. "Protective Effect of SolanumpubescensLINN on CCl4Induced Hepatotoxicity in Albino Rats." Mintage Journal of Pharmaceutical and Medicinal Science 1.1 (2012): 11-13.
  42. 42. Bhattacharyya, J., and Mara Z. de Almeida. "Isolation of the constituents of the root-bark of Guettarda platypoda." Journal of Natural Products 48.1 (1985): 148-149.
  43. 43. Rahman, Haseeb Ur, et al. "PHYTOCHEMICAL PROFILING OF SUCCESSIVE EXTRACTS OF FRUIT AND STEM BARK OF SOLANUM PUBESCENS."International Journal of Pharmacy and Pharmaceutical Sciences 6.9 (2014).
  44. 44. Mannan, Md Abdul, et al. "A Quick Review on Anti-diabetic Plants and Action of Phytochemicals." International Journal 2.5 (2014): 227-249.
  45. 45. Kumari, GN Krishna, L. Jagan Mohan Rao, and NS Prakasa Rao. "Flavonol 3-O-methyl ethers from Solanum pubescens." Journal of Natural Products 48.1 (1985): 149-150.
  46. 46. Hemamalini, K., and S. B. Sathya. "Hepatoprotective activity of Sophara interrupta and Holoptelea integrifolia against carbontetrachloride induced hepatotoxicity in rats." International Journal of Biology Pharmacy and Allied Sciences 2 (2013): 80-89.
  47. 47. Peesa, Jaya Preethi. "Herbal medicine for diabetes mellitus: A Review."International Journal of Phytopharmacy 3.1 (2013): 01-22.
  48. 48. Barbosa-Filho, José M., et al. "Plants and their active constituents from South, Central, and North America with hypoglycemic activity." Revista Brasileira de Farmacognosia 15.4 (2005): 392-413.
  49. 49. Arivoli, S., and Samuel Tennyson. "Studies on the Mosquitocidal Activity of (L.) Spreng (Rutaceae) Leaf Extracts Against, and (Diptera: Culicidae)."
  50. 50. Nagappa, A. N., et al. "Antidiabetic activity of< i> Terminalia catappa Linn fruits." Journal of Ethnopharmacology 88.1 (2003): 45-50.